Applied Biosciences Corp.
APPB · OTC
3/31/2021 | 3/31/2020 | 3/31/2019 | 3/31/2018 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.04 | -0.43 | -1.60 | -0.47 |
| FCF Yield | -27.35% | -1.13% | -0.57% | -0.22% |
| EV / EBITDA | -4.16 | -29.18 | -79.52 | -139.39 |
| Quality | ||||
| ROIC | -99.07% | -2,325.52% | -80.14% | -89.56% |
| Gross Margin | -358.52% | 39.65% | 26.21% | 21.26% |
| Cash Conversion Ratio | 0.98 | 0.27 | 0.34 | 0.28 |
| Growth | ||||
| Revenue 3-Year CAGR | -49.95% | 54.13% | 149.45% | 582,309.71% |
| Free Cash Flow Growth | 39.73% | -37.21% | -33.68% | -125.43% |
| Safety | ||||
| Net Debt / EBITDA | -0.38 | 0.04 | 0.01 | 0.03 |
| Interest Coverage | 0.00 | -3.06 | -4.08 | 0.00 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 3.42 | 6.63 | 5.35 |
| Cash Conversion Cycle | -433.10 | -404.81 | -26.02 | 39.85 |